Trial Profile
A Multicentre, Dose Optimisation Study to Assess the Consistency of Efficacy of Eletriptan for the Treatment of Migraine (With and Without Aura)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jan 2021
Price :
$35
*
At a glance
- Drugs Eletriptan (Primary)
- Indications Migraine with aura; Migraine without aura
- Focus Registrational; Therapeutic Use
- Sponsors Pfizer
- 16 May 2015 New trial record